Recordati Industria Chimica e Farmaceutica S.p.A. (LON:0KBS)

London flag London · Delayed Price · Currency is GBP · Price in EUR
53.88
-0.17 (-0.32%)
At close: Jul 25, 2025
-0.32%
Market Cap9.59B
Revenue (ttm)2.02B
Net Income (ttm)349.65M
Shares Outn/a
EPS (ttm)1.67
PE Ratio27.44
Forward PE16.43
Dividend1.07 (1.97%)
Ex-Dividend DateMay 19, 2025
Volume7,189
Average Volume11,703
Open53.43
Previous Close54.05
Day's Range53.60 - 54.05
52-Week Range44.04 - 60.95
Beta0.52
RSI54.64
Earnings DateJul 29, 2025

About LON:0KBS

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ... [Read more]

Industry Pharmaceutical Preparations
Founded 1926
Employees 4,583
Stock Exchange London Stock Exchange
Ticker Symbol 0KBS
Full Company Profile

Financial Performance

In 2024, LON:0KBS's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.